Synopsis
0
CEP/COS
0
EU WC
0
KDMF
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
FDA Orange Book
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
ANALYTICAL
ABOUT THIS PAGE
75
PharmaCompass offers a list of Pridinol API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Pridinol manufacturer or Pridinol supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Pridinol manufacturer or Pridinol supplier.
A pridinol monomesylate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of pridinol monomesylate, including repackagers and relabelers. The FDA regulates pridinol monomesylate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. pridinol monomesylate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of pridinol monomesylate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.
A pridinol monomesylate supplier is an individual or a company that provides pridinol monomesylate active pharmaceutical ingredient (API) or pridinol monomesylate finished formulations upon request. The pridinol monomesylate suppliers may include pridinol monomesylate API manufacturers, exporters, distributors and traders.
click here to find a list of pridinol monomesylate suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.
A pridinol monomesylate DMF (Drug Master File) is a document detailing the whole manufacturing process of pridinol monomesylate active pharmaceutical ingredient (API) in detail. Different forms of pridinol monomesylate DMFs exist exist since differing nations have different regulations, such as pridinol monomesylate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A pridinol monomesylate DMF submitted to regulatory agencies in the US is known as a USDMF. pridinol monomesylate USDMF includes data on pridinol monomesylate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The pridinol monomesylate USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of pridinol monomesylate suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The pridinol monomesylate Drug Master File in Japan (pridinol monomesylate JDMF) empowers pridinol monomesylate API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the pridinol monomesylate JDMF during the approval evaluation for pharmaceutical products. At the time of pridinol monomesylate JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of pridinol monomesylate suppliers with JDMF on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing pridinol monomesylate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for pridinol monomesylate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture pridinol monomesylate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain pridinol monomesylate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a pridinol monomesylate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of pridinol monomesylate suppliers with NDC on PharmaCompass.
pridinol monomesylate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of pridinol monomesylate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right pridinol monomesylate GMP manufacturer or pridinol monomesylate GMP API supplier for your needs.
A pridinol monomesylate CoA (Certificate of Analysis) is a formal document that attests to pridinol monomesylate's compliance with pridinol monomesylate specifications and serves as a tool for batch-level quality control.
pridinol monomesylate CoA mostly includes findings from lab analyses of a specific batch. For each pridinol monomesylate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
pridinol monomesylate may be tested according to a variety of international standards, such as European Pharmacopoeia (pridinol monomesylate EP), pridinol monomesylate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (pridinol monomesylate USP).
